Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 1
2004 4
2005 1
2006 4
2007 4
2009 4
2010 5
2011 6
2012 4
2013 4
2014 4
2015 2
2016 1
2017 2
2018 1
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
The complex of ferric-enterobactin with its transporter from Pseudomonas aeruginosa suggests a two-site model.
Moynié L, Milenkovic S, Mislin GLA, Gasser V, Malloci G, Baco E, McCaughan RP, Page MGP, Schalk IJ, Ceccarelli M, Naismith JH. Moynié L, et al. Among authors: page mgp. Nat Commun. 2019 Aug 14;10(1):3673. doi: 10.1038/s41467-019-11508-y. Nat Commun. 2019. PMID: 31413254 Free PMC article.
Siderophore conjugates.
Page MG. Page MG. Ann N Y Acad Sci. 2013 Jan;1277:115-26. doi: 10.1111/nyas.12024. Ann N Y Acad Sci. 2013. PMID: 23346861 Review.
Penicillin-binding proteins: evergreen drug targets.
Frère JM, Page MG. Frère JM, et al. Among authors: page mg. Curr Opin Pharmacol. 2014 Oct;18:112-9. doi: 10.1016/j.coph.2014.09.012. Epub 2014 Oct 14. Curr Opin Pharmacol. 2014. PMID: 25450065 Review.
What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.
Bush K, Page MGP. Bush K, et al. Among authors: page mgp. J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):113-132. doi: 10.1007/s10928-017-9506-4. Epub 2017 Feb 4. J Pharmacokinet Pharmacodyn. 2017. PMID: 28161807 Review.
Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General Porins.
Acosta-Gutiérrez S, Ferrara L, Pathania M, Masi M, Wang J, Bodrenko I, Zahn M, Winterhalter M, Stavenger RA, Pagès JM, Naismith JH, van den Berg B, Page MGP, Ceccarelli M. Acosta-Gutiérrez S, et al. Among authors: page mgp. ACS Infect Dis. 2018 Oct 12;4(10):1487-1498. doi: 10.1021/acsinfecdis.8b00108. Epub 2018 Aug 17. ACS Infect Dis. 2018. PMID: 29962203
Prospects for the next anti-Pseudomonas drug.
Page MG, Heim J. Page MG, et al. Curr Opin Pharmacol. 2009 Oct;9(5):558-65. doi: 10.1016/j.coph.2009.08.006. Epub 2009 Sep 12. Curr Opin Pharmacol. 2009. PMID: 19748829 Review.
Stemming the tide? Advances in antibiotic discovery and development in the face of emerging resistance and financial constraint.
Page MG, Kellenberger L. Page MG, et al. Curr Opin Pharmacol. 2012 Oct;12(5):519-21. doi: 10.1016/j.coph.2012.07.018. Epub 2012 Aug 10. Curr Opin Pharmacol. 2012. PMID: 22884906 No abstract available.
Cephalosporins in clinical development.
Page MG. Page MG. Expert Opin Investig Drugs. 2004 Aug;13(8):973-85. doi: 10.1517/13543784.13.8.973. Expert Opin Investig Drugs. 2004. PMID: 15268635 Review.
Anti-MRSA beta-lactams in development.
Page MG. Page MG. Curr Opin Pharmacol. 2006 Oct;6(5):480-5. doi: 10.1016/j.coph.2006.06.002. Epub 2006 Aug 8. Curr Opin Pharmacol. 2006. PMID: 16899405 Review.
Complexes formed by the siderophore-based monosulfactam antibiotic BAL30072 and their interaction with the outer membrane receptor PiuA of P. aeruginosa.
Scorciapino MA, Malloci G, Serra I, Milenkovic S, Moynié L, Naismith JH, Desarbre E, Page MGP, Ceccarelli M. Scorciapino MA, et al. Among authors: page mgp. Biometals. 2019 Feb;32(1):155-170. doi: 10.1007/s10534-018-00166-0. Epub 2019 Jan 11. Biometals. 2019. PMID: 30635814
51 results
Jump to page
Feedback